Physician profile
Michael K Eide
NPI 1710152061
$1,016.95
in general payments reported to CMS, 2019-2025
16 companies · $290 in 2025
The $290 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $63.85 · 2020: $13.96 · 2021: $89.89 · 2022: $125 · 2023: $143 · 2024: $291 · 2025: $290.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $724.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $723.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $295.47 | 2022-2025 | |
| Alcon Vision LLC | $160.50 | 2022-2025 | Clareon, Centurion, Tryptyr |
| Amgen INC. | $83.63 | 2024-2025 | Tepezza |
| Glaukos Corporation | $69.18 | 2024 | Istent Trabecular Micro-Bypass System Model Is3 |
| Tarsus Pharmaceuticals, INC. | $64.32 | 2024-2025 | Xdemvy |
| Alimera Sciences, INC. | $48.27 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $48.13 | 2022-2024 | Xiidra |
| Allergan, INC. | $39.57 | 2019-2021 | |
| Johnson & Johnson Surgical Vision, INC. | $34.46 | 2024 | Healon Duet Pro |
| Apellis Pharmaceuticals, INC. | $34.45 | 2022-2023 | Syfovre |
| Biotissue Holdings INC. | $34.39 | 2025 | |
| The Cameron-Ehlen Group, INC. | $28.30 | 2019 | |
| Rxsight INC | $24.72 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $22.83 | 2021 | |
| Sun Pharmaceutical Industries INC. | $17.62 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerie Pharmaceuticals, INC. | $11.11 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Eide listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.